<p>MCF7 (cancer) and MCF10 (non-tumorigenic) cells were treated with the PEMF paradigms producing the greatest amount of cell death in MCF7 (3 mT for 60 min/day for 3 consecutive days). (<b>A</b>) Dot plots generated by FCM analyses of MCF7 cells show greater increases in the proportions of cells in early (Annexin V+/PI-) and later stages of apoptosis (Annexin V+/PI+) in treated samples (left) relative to control (unexposed) samples (right). (<b>B</b>) MCF10 (non-tumorigenic) cells appear to be unharmed by PEMFs as underscored by the similar amounts of viable cells in treated (89%) versus unexposed (80%) cultures.</p
HL-60 and MCF-7 cells were treated with 0.15 μM camptothecin (CPT) or with the solvent dimethylsulfo...
<p>The cells were harvested and processed for apoptosis assay using the Annexin V-FITC Apoptosis Det...
<p>Cells were treated with <i>BP-C1</i> (750 µg/ml) for 48 h and Flow cytometric analysis of annexin...
<p>The apoptosis rate was detected by flow cytometry using the Annexin V-fluorescein isothiocyanate/...
<p>(<b>A</b>) Overlay of MCF7 cell populations treated with 2, 3 or 5 mT PEMF amplitudes at 20 Hz fo...
<p>Fibroblasts from different anatomical sites (Nodule, Cord, Fat and Skin) were treated with variou...
<p>ESCC cells stably expressing PHF8 or non-silencing shRNA, or control cells were stained with anne...
<p>A498 as well as MCF-10A cells were exposed to TLC fractions C4 and C5 (<i>Geitlerinema</i> sp. CC...
<p>(A) Apoptosis determined by flow cytometry in MDAMB231 cells treated with different DOX fomulatio...
<p>(<b>A</b>) Dot plots generated from MCF7 cell exposed to 2, 3 or 5 mT amplitude PEMFs for 60 minu...
<p>Cell viability as measured by Annexin V –/7-AAD – labeling (n = 3) in MCF and R3230Ac cells treat...
<p>Cells were treated for 30 to 120 sec and from 75 to 900 Hz frequency. The administered dose is ex...
<p>(A) FACS analysis of indicated subsets was performed by Annexin-V and 7AAD staining. The Annexin-...
<p>Representative distributions of the fluorescence intensity of annexin-V-FITC and PI binding of (a...
<p><b>Apoptotic assay was examined in MCF-7 cells treated with 100 μg/mL DESs for 48 h.</b> Cells we...
HL-60 and MCF-7 cells were treated with 0.15 μM camptothecin (CPT) or with the solvent dimethylsulfo...
<p>The cells were harvested and processed for apoptosis assay using the Annexin V-FITC Apoptosis Det...
<p>Cells were treated with <i>BP-C1</i> (750 µg/ml) for 48 h and Flow cytometric analysis of annexin...
<p>The apoptosis rate was detected by flow cytometry using the Annexin V-fluorescein isothiocyanate/...
<p>(<b>A</b>) Overlay of MCF7 cell populations treated with 2, 3 or 5 mT PEMF amplitudes at 20 Hz fo...
<p>Fibroblasts from different anatomical sites (Nodule, Cord, Fat and Skin) were treated with variou...
<p>ESCC cells stably expressing PHF8 or non-silencing shRNA, or control cells were stained with anne...
<p>A498 as well as MCF-10A cells were exposed to TLC fractions C4 and C5 (<i>Geitlerinema</i> sp. CC...
<p>(A) Apoptosis determined by flow cytometry in MDAMB231 cells treated with different DOX fomulatio...
<p>(<b>A</b>) Dot plots generated from MCF7 cell exposed to 2, 3 or 5 mT amplitude PEMFs for 60 minu...
<p>Cell viability as measured by Annexin V –/7-AAD – labeling (n = 3) in MCF and R3230Ac cells treat...
<p>Cells were treated for 30 to 120 sec and from 75 to 900 Hz frequency. The administered dose is ex...
<p>(A) FACS analysis of indicated subsets was performed by Annexin-V and 7AAD staining. The Annexin-...
<p>Representative distributions of the fluorescence intensity of annexin-V-FITC and PI binding of (a...
<p><b>Apoptotic assay was examined in MCF-7 cells treated with 100 μg/mL DESs for 48 h.</b> Cells we...
HL-60 and MCF-7 cells were treated with 0.15 μM camptothecin (CPT) or with the solvent dimethylsulfo...
<p>The cells were harvested and processed for apoptosis assay using the Annexin V-FITC Apoptosis Det...
<p>Cells were treated with <i>BP-C1</i> (750 µg/ml) for 48 h and Flow cytometric analysis of annexin...